Host Directed Therapies for Tuberculous Meningitis

A dysregulated host immune response significantly contributes to morbidity and mortality in tuberculous meningitis (TBM). Effective host directed therapies (HDTs) are critical to improve survival and clinical outcomes. Currently only one HDT, dexamethasone, is proven to improve mortality. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Angharad G., Donovan, Joseph, Bremer, Marise, Van Toorn, Ronald, Schoeman, Johan, Dadabhoy, Ariba, Lai, Rachel P.J., Cresswell, Fiona V, Boulware, David R, Wilkinson, Robert J, Thuong, Nguyen Thuy Thuong, Thwaites, Guy E, Bahr, Nathan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792876/
https://www.ncbi.nlm.nih.gov/pubmed/35118196
http://dx.doi.org/10.12688/wellcomeopenres.16474.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792876/
https://www.ncbi.nlm.nih.gov/pubmed/35118196
http://dx.doi.org/10.12688/wellcomeopenres.16474.2

Ejemplares similares